The flu virus and the coronavirus are very different. We

New Post Public Reply Private Reply Replies (2) Message Board
Drano petemantx #62640
418
The flu virus and the coronavirus are very different. We don't know what kind of effect a defensin mimetic will have on ANY virus.

What we know is that Brilacidin is a powerful anti-inflammatory and antibiotic.
Brilacidin per se (not some other defensin mimetic) seems likely to help with the EFFECTS of a viral infection -- the tremendous inflammation that can lead to multiple organ failure, and the secondary bacterial infections which are often what really kill a flu patient (and possibly the coronavirus patients -- we don't know enough yet to be able to say that).

As far as this "the flu kills more people than coronavirus" argument -- that is utter nonsense.
When people compare the death rate of a virus that has been well entrenched since last SEPTEMBER -- so has had 6 months to infect millions of people -- and a virus that has only been present in the U.S. for 6 WEEKS and has thus far only infected less than 100 people (that we know of) in this country -- that's absurd. Let's see what the statistics are in 6 months. I bet people will not be so sanguine about the "flu is worse" BS argument.

Here's something else for you to think about -- the death rate for the flu is a completely bogus figure.
They guess at how many people got the flu, based on hospital admissions. When you get sick, do you get a flu lab test to see if that's what you have, or if it's some other virus? Most people don't, because it doesn't matter anyway. You're sick, you need to either take an anti-viral like Tamiflu, or wait it out and hope you don't get really sick.
But then, going from NOT KNOWING how many flu cases there actually are -- when someone goes into the hospital after having been sick, and then dies from (typically) pneumonia, they ASSUME that this was a complication from flu. So if someone dies of pneumonia or multiple organ failure in a hospital during flu season, it is ASSUMED that it's attributable to flu -- even if it's not. There are plenty of other ways to get pneumonia.

So, you have a bogus made-up number of cases, and then more deaths are attributed to flu than are actually CAUSED by the flu, and voila ! ! ! Look at how dangerous flu is ! except that we have no idea of the true death rate.

And we don't know how many "flu" deaths were actually coronavirus. If it's been here for at least 6 weeks, some of those "pneumonia" deaths may have been from coronavirus.

"There are 3 kinds of lies -- lies, damned lies, and statistics." -- Mark Twain.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 353

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 395

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 8

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading

Top 5 Most Recently Viewed Articles

DENTSPLY SIRONA Inc. Faces Class Action for Alleged Fraud

Updated Category News Views 255

DENTSPLY SIRONA Inc. Faces Legal Challenges The law firm Kessler Topaz Meltzer & Check, LLP has informed investors about a securities class action lawsuit filed against DENTSPLY SIRONA Inc. (NASDAQ: XRAY). This lawsuit could have significant implications for investors who acquired DENTSPLY common stock between certain periods. Important Details for Investors Investors who...

Continue Reading
Revolutionizing Comfort in Urine Collection Systems

Updated Category News Views 166

Innovative External Urine Collection System An inventive individual from Stanwood has developed a groundbreaking external urine collection system aimed at improving comfort and health outcomes. The new system, known as the PART TIME CARETAKER, is designed to replace traditional indwelling urinary catheters. The inventor emphasizes the importance of comfort and reducing...

Continue Reading
Exploring Investors' Recent Movements in Apple Options

Updated Category News Views 132

Understanding Recent Investment Trends in Apple Options Recent activity in the options market shows that wealthy investors are betting on a positive outlook for Apple (NASDAQ:AAPL). This is notable for retail traders who closely monitor market dynamics. Insights from Option Trading Data Publicly available options trading history reveals an intriguing landscape of...

Continue Reading
Fat of the Land Expands to Irvine, Boosts Dining Scene

Updated Category News Views 30

Irvine Welcomes New Dining Destination And there it is, a fresh dining oasis gearing up to turn some heads out in Irvine. The Centerview is about to get even spicier with Fat of the Land, a celebrated tapas joint from Robert Paetz, making its way from Santa Ana to redefine what it means to dine in style. The Appeal of a ‘Third Space’ We’re not just talking about...

Continue Reading
Understanding Kaixin Holdings' Share Consolidation Strategy

Updated Category News Views 122

Key Announcement from Kaixin Holdings Kaixin Holdings, a prominent entity in the new energy vehicle sector, recently shared an important update regarding its financial structure. The company announced a share consolidation, which will take place at a ratio of 1-for-60. This consolidation is aimed at refining its capital structure and enhancing shareholder value. Details...

Continue Reading